Rad 242
| Code | Size | Price |
|---|
| TAR-T34253-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Rad 242 is a hydrophobic lidocaine derivative.
CAS:
103825-19-0
Formula:
C16H26N2O
Molecular Weight:
262.397
Purity:
0.98
SMILES:
CCCCCN(C)CC(=O)Nc1c(C)cccc1C
References
Liu L, Wendt DJ, Grant AO. Relationship between structure and sodium channel blockade by lidocaine and its amino-alkyl derivatives. J Cardiovasc Pharmacol. 1994 Nov;24(5):803-12. PubMed PMID: 7532759.
Grant AO, Dietz MA, Gilliam FR 3rd, Starmer CF. Blockade of cardiac sodium channels by lidocaine. Single-channel analysis. Circ Res. 1989 Nov;65(5):1247-62. PubMed PMID: 2553292.